Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Free Cash Flow (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Free Cash Flow readings, the most recent being -$14597.0 for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 82.37% to -$14597.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$268114.0, a 25.47% increase, with the full-year FY2025 number at -$329627.0, up 31.24% from a year prior.
  • Free Cash Flow reached -$14597.0 in Q1 2026 per CBIH's latest filing, down from -$5493.0 in the prior quarter.
  • The five-year high for Free Cash Flow was -$5493.0 in Q4 2025, with the low at -$221247.0 in Q4 2023.
  • A 4-year average of -$101680.1 and a median of -$82812.0 in 2025 define the central range for Free Cash Flow.
  • Year-over-year, Free Cash Flow surged 95.49% in 2024 and then crashed 812.43% in 2025.
  • Year by year, Free Cash Flow stood at -$221247.0 in 2023, then soared by 67.42% to -$72090.0 in 2024, then surged by 92.38% to -$5493.0 in 2025, then crashed by 165.74% to -$14597.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Free Cash Flow are -$14597.0 (Q1 2026), -$5493.0 (Q4 2025), and -$103712.0 (Q3 2025).